热门出版物 - 学术资源搜索

h5 指数:50
h5 中位数:67

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#8 Medicinal Chemistry

标题/作者	引用次数	年份
Molecular dynamics simulations and novel drug discovery X Liu, D Shi, S Zhou, H Liu, H Liu, X Yao Expert Opinion on Drug Discovery 13 (1), 23-37	277	2018
Broad-spectrum coronavirus antiviral drug discovery AL Totura, S Bavari Expert Opinion on Drug Discovery 14 (4), 397-412	205	2019
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy N Albadari, S Deng, W Li Expert Opinion on Drug Discovery 14 (7), 667-682	187	2019
Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics A Talevi, CL Bellera Expert Opinion on Drug Discovery 15 (4), 397-401	183	2020
Recent applications of click chemistry in drug discovery X Jiang, X Hao, L Jing, G Wu, D Kang, X Liu, P Zhan Expert Opinion on Drug Discovery 14 (8), 779-789	147	2019
An overview of spirooxindole as a promising scaffold for novel drug discovery LM Zhou, RY Qu, GF Yang Expert Opinion on Drug Discovery 15 (5), 603-625	142	2020
An overview of late-stage functionalization in today’s drug discovery M Moir, JJ Danon, TA Reekie, M Kassiou Expert Opinion on Drug Discovery 14 (11), 1137-1149	129	2019
Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery A Nocentini, CT Supuran Expert Opinion on Drug Discovery 14 (11), 1175-1197	120	2019
PROTACs–a game-changing technology M Konstantinidou, J Li, B Zhang, Z Wang, S Shaabani, F Ter Brake, ... Expert Opinion on Drug Discovery 14 (12), 1255-1268	113	2019
Artificial intelligence in drug discovery: recent advances and future perspectives J Jiménez-Luna, F Grisoni, N Weskamp, G Schneider Expert Opinion on Drug Discovery 16 (9), 949-959	104	2021
Open access in silico tools to predict the ADMET profiling of drug candidates S Kar, J Leszczynski Expert Opinion on Drug Discovery 15 (12), 1473-1487	99	2020
Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery CT Supuran Expert Opinion on Drug Discovery 15 (6), 671-686	92	2020
Binding affinity in drug design: experimental and computational techniques V Kairys, L Baranauskiene, M Kazlauskiene, D Matulis, E Kazlauskas Expert Opinion on Drug Discovery 14 (8), 755-768	91	2019
Vortioxetine: a novel antidepressant for the treatment of major depressive disorder X Gonda, SR Sharma, FI Tarazi Expert Opinion on Drug Discovery 14 (1), 81-89	85	2019
The discovery and development of topical medicines for wound healing E Öhnstedt, H Lofton Tomenius, E Vågesjö, M Phillipson Expert Opinion on Drug Discovery 14 (5), 485-497	85	2019
Challenges identifying efficacious miRNA therapeutics for cancer M Segal, FJ Slack Expert Opinion on Drug Discovery 15 (9), 987-991	84	2020
Phenotypic screening approaches for Chagas disease drug discovery E Chatelain, JR Ioset Expert Opinion on Drug Discovery 13 (2), 141-153	83	2018
Anticancer drug discovery using multicellular tumor spheroid models M Zanoni, S Pignatta, C Arienti, M Bonafè, A Tesei Expert Opinion on Drug Discovery 14 (3), 289-301	77	2019
Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer Y Zhong, YT Lu, Y Sun, ZH Shi, NG Li, YP Tang, JA Duan Expert Opinion on Drug Discovery 13 (1), 75-87	74	2018
Non-alcoholic fatty liver disease (NAFLD) models in drug discovery BK Cole, RE Feaver, BR Wamhoff, A Dash Expert Opinion on Drug Discovery 13 (2), 193-205	73	2018

1 - 20

计算机程序会自动估算并确定日期和引用次数。